Buy Retatrutide 20mg Peptide Pen UK | GLP-1 Research Peptide
Buy Retatrutide 20mg Peptide Pen UK | GLP-1 Research Peptide
Buy Retatrutide 20mg Peptide Pen UK | GLP-1 Research Peptide
Buy Retatrutide 20mg Peptide Pen UK | GLP-1 Research Peptide — Retatrutide 20mg in a precision peptide pen format, supplied for laboratory research purposes. Retatrutide is a synthetic triple agonist peptide targeting the GLP-1, GIP, and glucagon receptors simultaneously, manufactured to ≥99% purity and HPLC-verified for use in scientific research. The pen format offers a clear graduated scale and compact design suited to laboratory use. Dispatched from the UK with a Certificate of Analysis available upon request.
For in-vitro and laboratory research use only. Not for human or animal consumption, personal use, or self-administration.
Kit Contents
- 1 × Retatrutide 20mg Peptide Pen (pre-loaded, lyophilised)
Retatrutide 20mg Peptide Pen Research Information
Retatrutide (LY3437943) is an investigational peptide developed by Eli Lilly and Company. As a GLP-1 research peptide and triple incretin receptor agonist, it has been studied in preclinical and clinical research for its effects on metabolic pathways, energy homeostasis, and adipose tissue biology. The TRIUMPH-1 Phase 3 trial topline results (May 2026) reported a mean body weight reduction of 28.3% at 80 weeks, with 45.3% of participants achieving ≥30% weight reduction at the highest dose. The 20mg pen format offers a convenient precision delivery system for researchers.
Areas of Scientific Interest
- Triple incretin receptor agonism (GLP-1, GIP, glucagon)
- Metabolic rate and energy expenditure research
- Adipose tissue biology and lipid metabolism
- Insulin sensitivity and glucose homeostasis models
- Comparative agonist pharmacology across incretin receptor subtypes
- Body weight regulation and energy balance research
Product Specifications
- Product: Retatrutide 20mg Peptide Pen
- Quantity: 20mg
- Format: Pre-loaded precision peptide pen
- Purity: ≥99%
- Verification: HPLC-tested, Certificate of Analysis available
- Intended use: Research purposes only
- Storage: Store at −20°C, away from light and moisture
- Dispatched from the UK
Research Applications
The Retatrutide 20mg Peptide Pen is of significant interest across metabolic biology, endocrinology, and obesity research disciplines. The pen format provides precise, consistent volume delivery for laboratory research protocols. All applications are strictly for qualified laboratory research use.
Storage & Handling
Store the Retatrutide 20mg Peptide Pen at −20°C, protected from light and moisture. Handle under sterile laboratory conditions. For research use only.
Frequently Asked Questions
What is the Retatrutide 20mg Peptide Pen?
The Retatrutide 20mg Peptide Pen is a pre-loaded precision pen format GLP-1 triple agonist research peptide supplied strictly for in-vitro and laboratory research purposes.
Is the Retatrutide 20mg Peptide Pen available in the UK?
Yes. The Retatrutide 20mg Peptide Pen GLP-1 research peptide is dispatched from the UK with a Certificate of Analysis available upon request.
What purity is the Retatrutide 20mg Peptide Pen?
All Retatrutide 20mg Peptide Pen units are manufactured to ≥99% purity and independently HPLC-verified.
Can I buy the Retatrutide 20mg Peptide Pen in the UK for research?
The Retatrutide 20mg Peptide Pen is available for qualified laboratory research applications. It is not intended for human or animal use.
For research use only. Not for human consumption, therapeutic use, or veterinary use.
Also available in vial and higher-dose formats: Retatrutide 20mg Vial, Retatrutide 40mg Vial, Retatrutide 30mg Peptide Pen, Retatrutide 40mg Peptide Pen. Related research peptides: MOTS-C 10mg, NAD+ 500mg. View our full research peptide range. Further reading: What is Retatrutide? GLP-1 Research Guide.